| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |